PRP vs PRF: Tubes, Protocols & Clinical Applications Compared

Introduction

Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) represent two distinct generations of autologous platelet concentrate technology. While both derive from the patient's own blood and aim to deliver concentrated growth factors to target tissues, they differ fundamentally in their preparation chemistry, physical form, and growth factor release kinetics.

The choice between PRP and PRF begins with the tube — specifically, whether the tube contains an anticoagulant (PRP) or does not (PRF). This single design difference cascades through every aspect of the preparation process and clinical application. Understanding these differences is essential for protocol selection.

1. The Fundamental Difference: Anticoagulant vs No Anticoagulant

PRP Tubes

PRP tubes contain an anticoagulant — typically ACD-A or sodium heparin — that prevents the coagulation cascade from activating during and after blood collection. This preserves the blood in a liquid state, allowing centrifugation to separate it into layers (red blood cells, buffy coat/platelet layer, platelet-poor plasma) that remain physically distinct and recoverable.

Key consequence: PRP is a liquid preparation. It can be drawn into a syringe and injected through fine-gauge needles, applied topically during microneedling, or combined with other agents.

PRF Tubes

PRF tubes contain no anticoagulant. Blood collected into a PRF tube begins clotting immediately upon contact with the tube wall. The natural coagulation cascade proceeds, converting fibrinogen to fibrin and entrapping platelets within a three-dimensional fibrin matrix.

Key consequence: PRF is a solid or semi-solid fibrin clot/membrane. It cannot be injected through a needle. It is applied as a membrane, packed into a surgical site, or compressed into a plug.

2. Head-to-Head Comparison

Parameter	PRP	PRF
Tube additive	Anticoagulant (ACD-A, heparin)	None (additive-free)
Blood state after draw	Liquid (anticoagulated)	Clotting begins immediately
Centrifugation	Single or double spin, typically 1,500–3,500 RPM	Single spin, typically lower RPM (1,300–3,000 RPM)
Final product form	Liquid plasma suspension	Solid fibrin clot/membrane
Platelet concentration	2–7× baseline (protocol-dependent)	2–5× baseline (tube and spin dependent)
Leukocyte content	Variable (protocol-dependent)	Typically leukocyte-rich
Growth factor release	Rapid bolus release upon activation	Sustained release over 7–14 days from fibrin matrix
Injectable	Yes — through fine-gauge needle	No — applied as membrane or plug
Fibrin architecture	Minimal — liquid suspension	Dense 3D fibrin network
Primary applications	Aesthetics, hair restoration, orthopedics	Surgical sites, wound healing, bone grafting, dental

3. Growth Factor Release Kinetics: Why the Difference Matters

PRP: Bolus Release

In a liquid PRP preparation, platelets are suspended in plasma without a structural matrix. When PRP is injected into tissue or activated with calcium/thrombin, platelets degranulate rapidly, releasing their growth factor payload — PDGF, TGF-β, VEGF, EGF, IGF — in a concentrated burst over hours to approximately 1–2 days.

This bolus release profile is well-suited to applications where:

• A strong initial regenerative signal is desired
• The target tissue has adequate vascular supply to respond to the growth factor pulse
• Repeat treatments are planned to sustain the regenerative stimulus

PRF: Sustained Release

In a PRF clot, platelets are physically entrapped within the fibrin network. As the fibrin matrix is gradually degraded by plasmin and tissue proteases over 7–14 days, platelets are progressively exposed and release their growth factors in a sustained, time-extended manner.

This sustained release profile is advantageous in applications where:

• Prolonged growth factor exposure is desired (surgical sites, bone grafts)
• The target tissue has limited vascularity and benefits from extended signaling
• A single-application protocol is preferred

4. Tube Types by Application

PRP Tubes

Configuration	Typical Use
ACD-A + Gel Separator, 10ml	Full-face aesthetics, microneedling
ACD-A + Gel Separator, 12–15ml	Hair restoration, joint injection
Heparin + Gel Separator	Orthopedic protocols

PRF Tubes

Configuration	Typical Use
No additive, glass, 10ml	A-PRF (Advanced PRF) — dental, bone grafting
No additive, glass, 10ml, modified centrifugation	i-PRF (Injectable PRF) — liquid fibrinogen fraction before clotting
No additive, PET/glass, varied sizes	C-PRF (Concentrated PRF), Sticky Bone protocols

> Note on i-PRF: i-PRF protocols use PRF tubes (no anticoagulant) with modified, low-speed centrifugation to harvest a liquid fibrinogen-rich fraction before clotting completes. This is distinct from standard PRF protocols that produce a solid clot.

5. Choosing Between PRP and PRF

PRP is generally preferred when:

• Injectable delivery is required (joints, scalp, intradermal)
• Combination with microneedling or topical application
• A controlled, measurable liquid volume is needed
• Multiple treatment sessions are planned

PRF is generally preferred when:

• A surgical site requires a physical membrane or graft material
• Sustained, prolonged growth factor release is the clinical goal
• The procedure involves bone grafting, socket preservation, or soft tissue augmentation (dental, maxillofacial)
• A 100% autologous, additive-free preparation is desired or required

Combined PRP + PRF Protocols

Some protocols employ both preparations: PRP for injection into the treatment area (providing an immediate growth factor bolus) and PRF as a membrane or plug for sustained release. This dual approach is increasingly common in advanced dental and maxillofacial surgery.

6. Tube Quality for PRP and PRF

Regardless of whether you use PRP or PRF tubes, quality requirements are identical:

• CE marking: Confirm classification and conformity for your market
• ISO 13485 manufacturing: Systematic quality management from raw material to finished product
• Sterility: Individually packaged, EtO or gamma sterilized, single-use
• Batch traceability: Lot number on every unit, CoA available upon request
• Material: Medical-grade PET or glass, centrifugable at specified RPM

For PRF tubes specifically, verify that the internal surface treatment (or absence thereof) supports rapid, uniform clot formation without fragmenting during centrifugation.

PRP vs PRF is ultimately a protocol decision; the two product families are documented separately in the PRP tubes guide and the PRF tubes guide, each with configuration and quality criteria.

Frequently Asked Questions

Is one centrifugation cycle sufficient for PRP?

Single-spin protocols using properly designed gel separator tubes can produce PRP with adequate platelet concentration for many clinical applications. Double-spin protocols achieve higher concentration but add handling complexity.

Why does PRF require faster blood collection?

Because PRF tubes contain no anticoagulant, blood begins clotting upon contact with the tube wall. Rapid venipuncture and immediate transfer to the centrifuge (within 60–90 seconds) are essential to obtain a uniform clot before fibrin polymerization completes.

Can PRP tubes be used for PRF preparation?

No. PRP tubes contain anticoagulant, which prevents clot formation — the defining feature of PRF. Using a PRP tube for a PRF protocol will not produce a fibrin clot.

What is the optimal centrifugation speed for PRF?

Lower-speed protocols (typically 1,300–2,000 RPM, approximately 200–400 × g RCF) are associated with improved cell distribution within the fibrin clot and reduced cell damage. Protocol-specific optimization is recommended.

Is PRF better than PRP?

Neither is categorically "better" — they serve different clinical purposes. PRP provides an injectable liquid with rapid growth factor release; PRF provides a solid fibrin scaffold with sustained release. The appropriate choice depends on the clinical application.

Disclaimer: This article provides comparative information based on published literature and clinical usage patterns. It does not constitute medical advice or a recommendation for any specific treatment protocol. Always follow your local regulatory requirements, product Instructions for Use, and established clinical guidelines.

For CE-certified PRP tubes and additive-free PRF tubes manufactured under ISO 13485, explore the VivaPRP collection.